SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 28, 2022

NEW YORK, January 11, 2022 / PRNewswire / – The following statement is issued by Levi & Korsinsky, LLP:

To: Any person or entity who receives the securities of Instadose Pharma Corp. f / k / a Mikrocoze, Inc. (“Instadose” or the “Company”) (OTCMKTS: INSD) between December 8, 2020 and November 24, 2021. You are hereby notified that a securities class action lawsuit has been initiated in The United States District Court for the Eastern District of Virginia. For more information go to:

https://www.zlk.com/pslra-1/instadose-pharma-corp-fka-mikrocoze-inc-loss-submission-form?wire=4 or contact Joseph E. Levi, Esq. either by email to [email protected] or by phone at (212) 363-7500. There are no costs or obligations for you.

Instadose Pharma Corp. f / k / a Mikrocoze, Inc. NEWS – INSD NEWS

CASE DETAILS: According to the complaint filed: (i) Instadose had performed insufficient due diligence on the merger with Instadose Canada and / or ignored significant warning signs related to Instadose Canada; (ii) Instadose’s internal controls and policies were insufficient to detect and / or prevent improper trading activities by Company controls; (iii) the foregoing placed Instadose at increased risk of regulatory reviews and enforcement actions; and (iv) as a result, the Company’s public statements at all relevant times have been materially false and misleading.

WHAT THIS MEANS TO SHAREHOLDERS: If you’ve suffered a loss at Instadose, you’ve got up February 28, 2022 to request that the court appoint you as the lead plaintiff. Your ability to partake in a recovery does not require you to act as the lead plaintiff.

NO COST TO YOU: If you have Instadose Securities between December 8, 2020 and November 24, 2021 You may be entitled to compensation without paying any expenses or fees.

PROTECT YOUR FINANCIAL INTERESTS: Fill out this short submission form: https://www.zlk.com/pslra-1/instadose-pharma-corp-fka-mikrocoze-inc-loss-submission-form?wire=4 or call You 212- at. 363-7500 to discuss the case Joseph E. Levi, Esq

WHY LEVI & KORSINSKY: Levi & Korsinsky have a proven record of winning hundreds of millions of dollars worth of cases for shareholders over a period of 20 years. We represent and fight for shareholders who have been disadvantaged by companies.

Levi & Korsinsky is a nationally recognized company with offices in new York, California, Connecticut, and Washington, DC Founding partner of the company, Joseph Levi and Eduard Korsinsky, representing shareholders and institutional clients for nearly 20 years, have achieved remarkable results for clients in the US and internationally. The company, with more than 70 employees, is committed to promoting, maintaining and maintaining a culture of diversity, equality and inclusion for employees and those we represent. Our attorneys have extensive experience representing investors in securities disputes with a track record of recovering hundreds of millions of dollars in cases. Levi & Korsinsky was ranked one of the leading securities litigation firms in the SCAS Top 50 Report by Institutional Shareholder Services (“ISS”) for 7 years in a row The United States. The SCAS Top 50 Report identifies the leading securities law firms in the country, and year on year ISS has recognized Levi & Korsinsky as the leading law firm in securities class actions.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Comments are closed.